Person-centered care for Graves' disease
Part of Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests if a person-centered care approach improves well-being for people newly diagnosed with Graves' disease. You may receive extra support focused on your personal needs and goals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- This is your first time being diagnosed with Graves' disease.
- Your blood tests show high FT4 and/or FT3 (thyroid hormones) and you have a positive TRAb test.
- You do not have moderate or severe eye symptoms from Graves'.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new type of treatment called CAR-T cells (special immune cells made in a lab) to target and calm down the overactive immune system in people with severe Graves' disease that hasn't improved with standard medicines. It may offer a new option for those who have been on treatment for years or have had multiple relapses.
This study compares computer-guided dosing of methimazole (a common thyroid medication) to standard care for people with active Graves' disease. It tests whether digital support helps manage treatment better.
This study tests efgartigimod, a new medicine given by injection under the skin, to see if it can help control Graves' disease (an overactive thyroid condition). The goal is to reduce the need for other thyroid medications or help people stop taking them.
This trial is testing a new drug, BHV-1300, to see if it works and is safe for people with Graves' disease. It might be an option if you have active hyperthyroidism (overactive thyroid) caused by Graves' disease and haven't had certain other treatments.
This trial tests a personalized approach to treat thyroid disorders, either Graves’ disease or certain thyroid cancers that may need radioactive iodine treatment. It may help by matching treatment to your specific test results and needs.
This trial tests a new type of cell therapy called CAR-T cells made from a donor. The cells target B cells that may drive Graves' disease. It's for people whose Graves' disease has not gotten better with usual treatments.
Hear when a new Graves Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.